New York, NY, United States of America

Jennifer S Ito

This inventor holds 1 USPTO granted patent. Top assignee: K2 Biomicrosystems, LLC. Active years: 2015.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jennifer S. Ito: Innovator in Nucleic Acid Amplification Technology

Introduction

Jennifer S. Ito is a notable inventor based in New York, NY, who has made significant contributions to the field of biochemical monitoring. With a focus on nucleic acid amplification, she has developed a patented apparatus that enhances the monitoring of biochemical reactions using electromagnetic radiation.

Latest Patents

Jennifer has been awarded a patent for her invention titled "Nucleic Acid Amplification and Monitoring Apparatus." This innovative technology relates to the monitoring of biochemical amplification reactions, specifically designed for optical monitoring of isothermal and thermally-cycled amplification processes. The apparatus utilizes a wide range of electromagnetic radiation, from ultraviolet to infrared, providing a versatile method applicable to various biochemical amplification processes.

Career Highlights

Jennifer is associated with K2 Biomicrosystems, LLC, where she collaborates with a team of skilled professionals. Her career is marked by a commitment to advancing technologies in biochemical monitoring, contributing to the efficiency and accuracy of amplification techniques used in research and diagnostics.

Collaborations

In her professional journey, Jennifer has worked alongside colleagues such as David P. Klemer and Daniel Richard Klemer. These collaborations have played a crucial role in enhancing the development and application of her patented technology, fostering a creative environment for innovation within the team.

Conclusion

Jennifer S. Ito's inventive spirit and dedication to improving biochemical monitoring through her patented apparatus have positioned her as a key figure in her field. As she continues her work with K2 Biomicrosystems, LLC, her innovations promise to impact the realm of nucleic acid amplification and monitoring significantly.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…